Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria Group news has been bad for years - with yet another blow with regards to the Juul investment recently. The money is already lost, going forward, Altria should continue to produce steady earnings growth.

Altria: Bad News Is Good News

Boise Cascade

B&G Foods

Lumen Technologies

Omega Healthcare Investors

Pioneer Natural Resources

B. Riley Financial

As interest rates increase, searching for quality companies with ultra-high dividend stocks is even more vital for income investors looking to deliver on their retirement dreams. At the beginning of 2022, the S&P 500 yield was 1.27%.

7 Ultra-High Dividend Stocks for Income Investors

Since 2016, the U.S. Food and Drug Administration has sought to crack down on fruity, sweet-flavored e-cigarettes that hook teenagers on nicotine.

New 'candy' e-cigs catch fire after U.S. regulators stamp out Juul's flavors

Altria Group, Inc. (NYSE:MO) is an American corporation and one of the world's largest producers and marketers of tobacco, cigarettes, and related products.

Juul Buzz Shifts Altria Stock Higher

Altria sold off recently as they wrote down their Juul investment. The company is trading under 10x earnings, well below the average multiple of 14.1x.

Altria: The Valuation Is Too Cheap For This High Margin Cash Cow

Anheuser-Busch InBev

Not selling this multi-billion dollar stake could pay off big.

10.6 Billion Reasons to Buy This Ultra-High Dividend Stock

Lockheed Martin

Pfizer

AT&T

In general, the biggest reason for holding dividend stocks is to generate regular cash flows. Furthermore, dividend stocks are typically low-beta stocks and help in balancing overall portfolio risk.

4 Dividend Stocks Set to Move Significantly Higher This Year

Best Buy

Gladstone Commercial

ONEOK

Simon Property Group

Vornado Realty Trust

In a logical world, one would think that, with the Federal Reserve raising interest rates all year long, rates across the entire Treasury yield curve would be headed higher.

Yields Plunge After Inflation Report: These 7 ‘Strong Buy' Stocks Have Huge Dividends

Coca-Cola

Procter & Gamble

KO, MO and PG earnings shed light on the state of the consumer.

Pockets of Strength in Consumer Staples Stocks: KO, MO, PG Earnings

The tobacco giant has been beaten down after a series of misfortunes.

Is Altria a Buy?

Devon Energy

Intel

LyondellBasell Industries

Medical Properties Trust

Suncor Energy

T. Rowe Price Group

Investors have fewer deep value stocks to pick from after the latest rally. Retail investors had enough of the bear market by late June when the S&P 500 bottomed at below 3700.

7 Deep Value Stocks for Income and High Total Returns

Healthpeak Properties

Investing roughly $55,500 across these stocks will be enough to generate $300 in monthly dividend payments.

Want $300 in Passive Income Every Month? Invest in These 3 Stocks

Dollar General

These stocks can help you balance opportunity and risk in today's volatile market.

3 Safe Stocks to Buy Even if the 2022 Bear Market Is Far From Over

Altria Group's adjusted diluted EPS payout ratio is set to improve from an already safe 75.5% in 2021 to 74.9% in 2022. Adjusting for the sale of its wine business last year, the tobacco company's first-half revenue net of excise taxes edged slightly higher while adjusted diluted EPS increased 3.5% year-to-date.

Altria Group: A Pay Raise From This Ultra-High-Yielder May Be Around The Corner

Philip Morris

Investors love both stocks, but only one can be best-in-show.

Altria or Philip Morris International: Which Stock Should You Buy Now?

As of Q2 2022, Altria's JUUL investment has pretty much all vaporized (pun intended) with its valuation estimated at only $450M. It is an epic failure that will be used as a case study in textbooks.

Altria's JUULess Future

Altria (MO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Is Most-Watched Stock Altria Group, Inc. (MO) Worth Betting on Now?

The days of smoking hot returns from this giant are over. This quarter's results, once again, showed the amount of effort that is needed to keep profits steady.

Altria: The 3 Certainties In Life

Bank of Nova Scotia

Enbridge

Federal Realty Investment Trust

V.F.

The market was up 9% in July, the best month since November 2020. The rally was mostly based on the delusional belief the Fed will soon pivot. Some economist models think CPI might not peak until early next year at 10.1%. The Fed's most dovish President has said no pivot is coming anytime soon.

6 High-Yield Blue-Chips You'll Want To Own When The Market Crashes Again

Digital Realty Trust

Johnson & Johnson

Microsoft

The US has likely entered a recession, as GDP has dropped two quarters in a row. Not all equities will be equally impacted by a recession.

5 Dependable Stocks To Hedge Against A Recession

The Juul purchase is viewed with a historical perspective. Altria appeared to be in a panic about Juul's growth, and Wall Street was on board with the $12.8 billion investment.

Altria: Juul Vaporized, Almost

Altria wrote down the value of its JUUL equity investment by $1.2B in the second quarter. EPS guidance for FY 2022 was confirmed.

Altria: 8.2% Yield, Confirmed 2022 Guidance, Upside Potential

Fears about JUUL have been overplayed and are largely irrelevant. MO will almost certainly continue to pay out 80% of adjusted earnings.

Altria: A Simple Dividend Forecast

Altria saw declines in both its revenues and operating income in Q2 as macro headwinds led to an 11% drop in its cigarette volume. However, the results were made worse by some one-off items, and Altria reiterated its outlook for a 4-7% EPS growth in 2022.

Altria: Why Investors Should Look Past Q2 Revenue And Profit Decline

Altria Group, Inc. (NYSE:MO ) Q2 2022 Earnings Conference Call July 28, 2022 9:00 AM ET Company Participants Mac Livingston - Vice President of Investor Relations, Altria Client Services Billy Gifford - Chief Executive Officer Sal Mancuso - Executive Vice President & Chief Financial Officer Conference Call Participants Chris Growe - Stifel Pamela Kaufman - Morgan Stanley Vivien Azer - Cowen & Company Bonnie Herzog - Goldman Sachs Gaurav Jain - Barclays Jennifer Maloney - The Wall Street Journal Operator Good day, and welcome to the Altria Group 2022 Second Quarter and First Half Earnings Conference Call. Today's call is scheduled to last about 1 hour, including remarks by Altria's management and a question-and-answer session.

News for Altria Stock (MO)